Investors / United States / Modi Ventures
Modi Ventures
Venture capital · Houston, TX, United States · North America
Modi Ventures invests in both venture funds and founders, with a focus on the intersection of technology and biology. It makes early stage investments in technology platforms intended to have a positive impact on health.
Invests inHealthcare & Biotech
In its own wordstechbioartificial intelligencemultiomicsgene editingprecision medicinesynthetic biology
Your fit with Modi Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsModi Ventures lists 35 checked portfolio companies on its own site and is named in 12 funding rounds, 3 of them as lead. Its most frequent entry is Seed, 55% of the companies with a known first round. Its largest themes are Healthcare & Biotech (73%), AI & Machine Learning (15%) and Cybersecurity (2%). 71% of its companies are based in United States. It invests most often alongside ARTIS, AIX Ventures and DCVC.
Counts come from funding rounds that name Modi Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Modi Ventures' whole history. Rounds on record name 11 companies; its own site lists 35. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 55% |
| Series A | 18% |
| Series B | 18% |
| Growth | 9% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 4 | 1 |
| '26 | 8 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 73th | 35 companies |
| Recent activity | 93th | 8 rounds in 12 months |
| Early stage | 73th | 55% of entries at pre-seed or seed |
| Evidence | 93th | 23% of companies confirmed by a round |
| Sector focus | 92th | 73% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| ARTIS | 4 |
| AIX Ventures | 3 |
| DCVC | 3 |
| Flagship Pioneering | 3 |
| IQT | 3 |
| LifeArc Ventures | 3 |
| nVentures | 3 |
| Abstract | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers35100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 73% | 15% |
| AI & Machine Learning | 15% | 18% |
| Cybersecurity | 2% | 4% |
| Enterprise Software | 2% | 8% |
| Industrial & Manufacturing | 2% | 7% |
| Consumer | 2% | 3% |
| E-commerce & Marketplaces | 2% | 6% |
Co-investor network
who it backs companies with, and who they back togetherCompare Modi Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Modi Ventures| Date | Company | Stage |
|---|---|---|
| 29 Oct 2026 | Series B Led | |
| 29 Sept 2026 | Series A | |
| 10 Jun 2026 | Seed | |
| 8 May 2026 | Seed Led | |
| 5 May 2026 | Series A | |
| 24 Feb 2026 | Series C+ | |
| 20 Jan 2026 | Series B | |
| 13 Jan 2026 | Seed |
Round details for Modi Ventures
Amounts, full round histories and every co-investor in Modi Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
35 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aether Bio discovers proteins with high-impact applications, including building super materials and processing critical minerals, using artificial intelligence and robotic high-throughput screening labs. | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| Brainomix develops and provides AI-powered imaging software for brain and lung scans | Healthcare & Biotech | Feb 2026Series C+ | Page + round | |
| Breye Therapeutics develops novel, orally administered ophthalmology drugs to meet the needs of patients at risk of vision loss. | Healthcare & Biotech | Sept 2026Series A | Page + round | |
| Case45 develops zero-shot AI for oncology. | Healthcare & Biotech | Portfolio page | ||
| Cytospire Therapeutics develops next generation immune cell engagers, including multispecific antibodies and gamma delta T cell engagers, for cancer therapies. | Healthcare & Biotech | May 2026Series A | Page + round | |
| Early is a company that offers a urine test that screens for markers linked to serious disease and wellness. | Healthcare & Biotech | Portfolio page | ||
| Elemind develops a wearable neurotechnology headband to help people fall asleep faster and improve sleep efficiency | Healthcare & Biotech | Portfolio page | ||
| Eridu AI develops networking technology for artificial intelligence applications | AI & Machine LearningCybersecurity | Portfolio page | ||
| Evity is building a medical AI platform to help people live healthier and longer lives. | Healthcare & Biotech | Portfolio page | ||
| Exciva is developing a groundbreaking therapy that effectively and safely addresses neuropsychiatric symptoms including agitation in patients with Alzheimer’s disease dementia. | Healthcare & Biotech | Jan 2026Series B | Page + round | |
| General Proximity develops programmable medicines based on proximity mechanisms to control biology | Healthcare & Biotech | Portfolio page | ||
| Glyphic Biotechnologies is developing a high-throughput proteome sequencing technology | Healthcare & Biotech | Portfolio page | ||
| Groq operates a cloud platform for running AI inference, built on its own LPU chips and combined with NVIDIA GPUs. | AI & Machine LearningEnterprise Software | Portfolio page | ||
| HeartX works with medtech/healthtech companies to educate them about the U.S. healthcare market and facilitate pilot projects and clinical trials with clinical partners | Healthcare & Biotech | Portfolio page | ||
| Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients. | Healthcare & Biotech | Feb 2025Seed | Page + round | |
| Imagenomix uses AI to predict genetics from pathology slides to help with targeted cancer therapy | Healthcare & Biotech | May 2026Seed | Page + round | |
| Kamau Therapeutics engineers long-lived stem cells to create precise therapeutic changes with the potential to carry forward over time. | Healthcare & Biotech | Portfolio page | ||
| Komo Biosciences develops non-viral platforms for precise DNA insertion and targeted gene integration technology | Healthcare & Biotech | Portfolio page | ||
| The company develops gene therapies designed to target the right cell types in the right tissues, to fundamentally impact genetic diseases | Healthcare & Biotech | Portfolio page | ||
| LILA generates hypotheses, designs and runs experiments, and learns from new data in real time using advanced AI and autonomous labs | AI & Machine LearningHealthcare & Biotech | Mar 2025Seed · 2 rounds | Page + round |
About this data
site last read 12 Nov 2026- Site
- modivc.com
- Last read
- 12 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 26 Feb 2025
- Companies checked
- 35
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Modi Ventures' profile as data
Pull Modi Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/modivc.com
# also
GET /v1/firms/modivc.com/portfolio
GET /v1/firms/modivc.com/coinvestors
GET /v1/firms/modivc.com/news